{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:08:27Z","timestamp":1790536107615,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,25]]},"DOI":"10.7759\/cureus.19882","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:05:29Z","timestamp":1637838329000},"source":"Crossref","is-referenced-by-count":9,"title":["Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Manu","family":"Madan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhvya","family":"Baldwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanima","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Hadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randeep","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/traa025","article-title":"COVID-19: a fast evolving pandemic","volume":"114","author":"Whitworth J","year":"2020","unstructured":"Whitworth J. COVID-19: a fast evolving pandemic. Trans R Soc Trop Med Hyg. 2020, 114:241-8. 10.1093\/trstmh\/traa025","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-13. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4031","article-title":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response","volume":"323","author":"Grasselli G","year":"2020","unstructured":"Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020, 323:1545-6. 10.1001\/jama.2020.4031","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1788_20","article-title":"Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India","volume":"152","author":"Mohan A","year":"2020","unstructured":"Mohan A, Tiwari P, Bhatnagar S, et al.. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020, 152:61-9. 10.4103\/ijmr.IJMR_1788_20","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel U","year":"2020","unstructured":"Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. JAMA. 2020, 323:2340-1. 10.1001\/jama.2020.8189","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2720-9","article-title":"BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?","volume":"11","author":"Sharma A","year":"2020","unstructured":"Sharma A, Kumar Sharma S, Shi Y, et al.. BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?. Cell Death Dis. 2020, 11:516. 10.1038\/s41419-020-2720-9","journal-title":"Cell Death Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2020.05.042","article-title":"TB infection and BCG vaccination: are we protected from COVID-19?","volume":"185","author":"Madan M","year":"2020","unstructured":"Madan M, Pahuja S, Mohan A, et al.. TB infection and BCG vaccination: are we protected from COVID-19?. Public Health. 2020, 185:91-2. 10.1016\/j.puhe.2020.05.042","journal-title":"Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.10.20033795","article-title":"Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity","author":"Chen Y","year":"2020","unstructured":"Chen Y, Wang Y, Fleming J, et al.. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv. 2020, 10.1101\/2020.03.10.20033795","journal-title":"medRxiv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.20.0163","article-title":"Severe COVID-19 cases with a history of active or latent tuberculosis","volume":"24","author":"Liu C","year":"2020","unstructured":"Liu C, Yu Y, Fleming J, et al.. Severe COVID-19 cases with a history of active or latent tuberculosis. Int J Tuberc Lung Dis. 2020, 24:747-9. 10.5588\/ijtld.20.0163","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref12","unstructured":"MOHFW-GOI. Guidance note on bi-directional TB-COVID screening and screening of TB among ILI\/SARI cases. (2020). Accessed. November 16, 2021: https:\/\/www.mohfw.gov.in\/pdf\/1TBCOVIDscreeningguidancenote.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.93479","article-title":"Mantoux test and its interpretation","volume":"3","author":"Nayak S","year":"2012","unstructured":"Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012, 3:2-6. 10.4103\/2229-5178.93479","journal-title":"Indian Dermatol Online J"},{"key":"ref14","unstructured":"Mantoux tuberculin skin test USA. Centers for Disease Control and Information. (2021). Accessed: November 16, 2021: https:\/\/www.cdc.gov\/tb\/education\/mantoux\/default.htm."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.061","article-title":"Mild versus severe COVID-19: laboratory markers","volume":"95","author":"Velavan TP","year":"2020","unstructured":"Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis. 2020, 95:304-7. 10.1016\/j.ijid.2020.04.061","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis","volume":"25","author":"Ghahramani S","year":"2020","unstructured":"Ghahramani S, Tabrizi R, Lankarani KB, et al.. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020, 25:30. 10.1186\/s40001-020-00432-3","journal-title":"Eur J Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis","volume":"96","author":"Zhao Q","year":"2020","unstructured":"Zhao Q, Meng M, Kumar R, et al.. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis. Int J Infect Dis. 2020, 96:131-5. 10.1016\/j.ijid.2020.04.086","journal-title":"Int J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/tru058","article-title":"The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review","volume":"108","author":"Peto L","year":"2014","unstructured":"Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Van Kinh N, Wertheim HF. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014, 108:326-37. 10.1093\/trstmh\/tru058","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a068979","article-title":"Clinical profile, laboratory characteristics and outcome in miliary tuberculosis","volume":"88","author":"Sharma SK","year":"1995","unstructured":"Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC. Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM. 1995, 88:29-37. 10.1093\/oxfordjournals.qjmed.a068979","journal-title":"QJM"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03408-2020","article-title":"A profile of a retrospective cohort of 22 patients with COVID-19 and active\/treated tuberculosis","volume":"56","author":"Gupta N","year":"2020","unstructured":"Gupta N, Ish P, Gupta A, et al.. A profile of a retrospective cohort of 22 patients with COVID-19 and active\/treated tuberculosis. Eur Respir J. 2020, 56:2003408. 10.1183\/13993003.03408-2020","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01398-2020","article-title":"Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases","volume":"56","author":"Tadolini M","year":"2020","unstructured":"Tadolini M, Codecasa LR, Garc\u00eda-Garc\u00eda JM, et al.. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020, 56:2001398. 10.1183\/13993003.01398-2020","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2020.05.002","article-title":"Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts","volume":"26","author":"Motta I","year":"2020","unstructured":"Motta I, Centis R, D'Ambrosio L, et al.. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020, 26:233-40. 10.1016\/j.pulmoe.2020.05.002","journal-title":"Pulmonology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01708-2020","article-title":"Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital","volume":"56","author":"Stochino C","year":"2020","unstructured":"Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020, 56:2001708. 10.1183\/13993003.01708-2020","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack U","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, et al.. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009, 33:956-73. 10.1183\/09031936.00120908","journal-title":"Eur Respir J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100073","article-title":"Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study","volume":"1","author":"Moorlag SJ","year":"2020","unstructured":"Moorlag SJ, van Deuren RC, van Werkhoven CH, et al.. Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study. Cell Rep Med. 2020, 1:100073. 10.1016\/j.xcrm.2020.100073","journal-title":"Cell Rep Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207687","article-title":"The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection","volume":"71","author":"Seddon JA","year":"2016","unstructured":"Seddon JA, Paton J, Nademi Z, et al.. The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection. Thorax. 2016, 71:932-9. 10.1136\/thoraxjnl-2015-207687","journal-title":"Thorax"},{"key":"ref27","article-title":"","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization, Geneva, Switzerland; 2018. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260233\/9789241550239-eng.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78004-impact-of-latent-tuberculosis-on-severity-and-outcomes-in-admitted-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:10Z","timestamp":1707507070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78004-impact-of-latent-tuberculosis-on-severity-and-outcomes-in-admitted-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.19882","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}